Oct 24, 2024 · As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.

AbbVie is committed to helping patients get the medicines they need. That’s why we offer patient assistance programs that provide free AbbVie medicines to qualifying patients. Our Patient Assistance Programs are intended for people that live in the United States, have limited or no health insurance coverage and demonstrate qualifying ...

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois.It is ranked sixth on the list of largest biomedical companies by revenue.In 2023, the company's seat in Forbes Global 2000 was 74, [2] and rank 89 on the 2024 list. [3] The company's primary product is Humira (adalimumab) ($14 billion in 2023 revenues, 27 percent of total), …

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013.

Oct 24, 2024 · AbbVie discovers and delivers innovative medicines and solutions that enhance people’s lives. Go To Page. Positions & Views; Explore our history; October 24, 2024 Profile. AbbVie’s 2024 Working Parents: Finding Purpose in Adversity.

13 hours ago · AbbVie ABBV announced strong fourth-quarter 2024 results last week, beating estimates for both earnings and sales. While earnings of $2.16 per share declined around 22% year over year, sales rose ...

AbbVie announced that it completed its acquisition of Nimble Therapeutics, strengthening AbbVie 's pipeline and R&D capabilities. The transaction includes Nimble's lead asset, an investigational oral peptide IL23R inhibitor in preclinical development for the treatment of psoriasis (PsO) as well as Nimble's peptide synthesis, screening, and ...

Jan 23, 2025 · AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include, but are not limited to, challenges to intellectual property, competition from other products ...

AbbVie is not expected to receive a tangible benefit/business outcome. Our Grants and Donations policy does not allow the involvement of a business outcome. Type of requests that will be considered for funding: From institutions and organizations that align with, and embrace AbbVie’s values with respect to equity, equality, diversity and ...

AbbVie discovers, develops, and commercializes advanced therapies that have an impact on people's lives. Today, our passionate AbbVie team has approximately ~50,000 employees working together to help patients around the world.